Standard chemotherapy with cetuximab for treatment of colorectal cancer

doi:10.3748/wjg.v21.i22.7022

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 21, Issue 22

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7225)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-11) series, Tables (1-2) series.

Item

Count

PDF

440

WORD

160

HTML

3872

Figures (1-11)

217

Tables (1-2)

198

Sum=4887

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1044

Download

1294

Sum=2338

Jun 14, 2015 (publication date) through Dec 25, 2024

Times Cited of This Article

Times Cited (7)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Meta-Analysis

World J Gastroenterol. Jun 14, 2015; 21(22): 7022-7035
Published online Jun 14, 2015. doi: 10.3748/wjg.v21.i22.7022

Full Size Figure Download Figure

Figure 9 Meta-analysis of effect of cetuximab plus irinotecan containing chemotherapy on progression-free survival based on status of KRAS.

Citation: Li XX, Liang L, Huang LY, Cai SJ. Standard chemotherapy with cetuximab for treatment of colorectal cancer. World J Gastroenterol 2015; 21(22): 7022-7035
URL: https://www.wjgnet.com/1007-9327/full/v21/i22/7022.htm
DOI: https://dx.doi.org/10.3748/wjg.v21.i22.7022